Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Apr;51(3):830-832.
doi: 10.1007/s11239-020-02253-x. Epub 2020 Aug 20.

Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis

Mohamed Abdel-Maboud  1   2 , Amr Menshawy  3 , Ahmed Elgebaly  4 , Eshak I Bahbah  5 , Gehad El Ashal  6 , Ahmed Negida  7   8
Affiliations
Meta-Analysis

Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis

Mohamed Abdel-Maboud et al. J Thromb Thrombolysis. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors confirm no financial or personal relationship with a third party whose interests could be positively or negatively influenced by the article’s content.

Figures

Fig. 1
Fig. 1
a Shows a forest plot of the pooled risk ratio of mortality between the prophylactic heparin and non-prophylactic heparin groups with the corresponding 95% confidence intervals. b Shows the overall meta-regression risk ratio of the interaction between severity/D-dimer on x-axis and mortality on y-axis
See this image and copyright information in PMC

References

    1. Wichmann D, Sperhake J-P, Lütgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med. 2020 doi: 10.7326/M20-2003. - DOI - PMC - PubMed
    1. Shi C, Wang C, Wang H, Yang C, Cai FEI, Zeng F, et al. The potential of low molecular weight heparin to mitigate cytokine storm in severe covid-19 patients: a retrospective clinical study. medRxiv. 2020 doi: 10.1101/2020.03.28.20046144. - DOI - PMC - PubMed
    1. Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020;18:786–787. doi: 10.1111/jth.14781. - DOI - PMC - PubMed
    1. Thachil J. The versatile heparin in COVID-19. J Thromb Haemost. 2020;18(5):1020–1022. doi: 10.1111/jth.14821. - DOI - PMC - PubMed
    1. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099. doi: 10.1111/jth.14817. - DOI - PMC - PubMed

MeSH terms